ANI PHARMACEUTICALS INC. - COMMON STOCK

ANI Pharmaceuticals to Present at Raymond James’ Institutional Investors and Leerink Partners Global Healthcare Conferences in March

19 Feb 2025 15:30:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025, at 8:00 a.m. ET

18 Feb 2025 15:05:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at the Guggenheim Biotech Conference

28 Jan 2025 15:30:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Provides Preliminary Fourth Quarter and 2024 Financial Results and Preliminary 2025 Outlook

13 Jan 2025 05:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity

02 Jan 2025 05:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

30 Dec 2024 15:05:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference

26 Nov 2024 15:30:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance

08 Nov 2024 05:50:28 By Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November

04 Nov 2024 15:30:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET

30 Oct 2024 16:00:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%

25 Oct 2024 05:50:54 By Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024

24 Oct 2024 05:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%

26 Sep 2024 05:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences

16 Sep 2024 07:53:27 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences

16 Sep 2024 05:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Launches Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution

13 Sep 2024 05:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger

11 Sep 2024 05:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences

10 Sep 2024 13:09:55 By Nasdaq GlobeNewswire

ANI Pharmaceuticals, Inc. Closes $316.25 Million Convertible Senior Notes Offering Including Full Exercise of Initial Purchasers’ Option to Purchase Additional Notes

13 Aug 2024 15:05:27 By Nasdaq GlobeNewswire

ANI Pharmaceuticals, Inc. Prices Upsized $275.0 Million Convertible Senior Notes Offering

07 Aug 2024 20:44:18 By Nasdaq GlobeNewswire